海尔生物
(688139)
| 流通市值：81.71亿 | | | 总市值：81.71亿 |
| 流通股本：3.18亿 | | | 总股本：3.18亿 |
| 报告期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,151,899,865.06 | 1,319,514,483.34 | 1,269,279,665.66 | 1,288,305,956.44 |
| 应收票据及应收账款 | 393,451,647.22 | 340,725,221.09 | 198,490,057.39 | 267,754,767.36 |
| 其中：应收票据 | 1,708,273.56 | 6,016,861.79 | 10,812,393.38 | 11,795,590.62 |
| 应收账款 | 391,743,373.66 | 334,708,359.3 | 187,677,664.01 | 255,959,176.74 |
| 应收款项融资 | 9,989,221.36 | 7,956,020.69 | 9,858,432 | 12,595,352.96 |
| 预付款项 | 19,290,706.62 | 13,757,238 | 18,986,138.45 | 19,497,246.19 |
| 其他应收款合计 | 9,301,742.7 | 7,317,947.58 | 7,470,708.63 | 8,902,957.16 |
| 存货 | 244,993,394.53 | 250,844,999.65 | 248,019,202.28 | 198,252,598.05 |
| 合同资产 | 1,789,666.34 | - | - | - |
| 一年内到期的非流动资产 | 151,235,412.36 | 109,003,194 | 108,105,833 | - |
| 其他流动资产 | 21,158,796.47 | 18,167,125.78 | 24,677,943.11 | 15,695,557.37 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,405,604,989.66 | 2,748,960,813.13 | 2,536,028,043.52 | 2,636,531,294.08 |
| 非流动资产: | | | | |
| 长期股权投资 | 133,181,471.47 | 131,295,622.38 | 130,300,034 | 126,028,666.12 |
| 其他权益工具投资 | 28,199,861.65 | 56,878,493.06 | 56,878,493.06 | 72,542,333.27 |
| 其他非流动金融资产 | 9,000,000 | 9,000,000 | 9,000,000 | - |
| 投资性房地产 | 9,241,985.97 | 9,429,386.25 | 9,626,308.47 | 9,818,469.72 |
| 固定资产 | 810,585,608.69 | 773,513,479.24 | 779,564,272.26 | 761,969,373.61 |
| 在建工程 | 77,351,106.94 | 87,817,966.53 | 70,333,719.42 | 81,249,355.05 |
| 使用权资产 | 12,539,069.54 | 11,326,751.64 | 12,320,322.63 | 12,860,801.82 |
| 无形资产 | 425,371,371.98 | 357,703,925.55 | 367,727,127.7 | 370,755,878.8 |
| 商誉 | 757,755,028.67 | 642,629,062.25 | 642,678,363.46 | 642,365,428.83 |
| 长期待摊费用 | 6,713,900.47 | 5,325,477.72 | 5,693,496.49 | 6,064,681.93 |
| 递延所得税资产 | 62,592,740.56 | 57,658,178.38 | 51,673,543.29 | 45,421,554.58 |
| 其他非流动资产 | 848,584,539.19 | 795,296,473.02 | 853,858,844.37 | 726,759,134.21 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,181,116,685.13 | 2,937,874,816.02 | 2,989,654,525.15 | 2,855,835,677.94 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,586,721,674.79 | 5,686,835,629.15 | 5,525,682,568.67 | 5,492,366,972.02 |
| 流动负债: | | | | |
| 短期借款 | 21,104,670.4 | 11,010,694.44 | 6,006,328.77 | 6,004,277.78 |
| 应付票据及应付账款 | 423,326,041.66 | 497,253,159.53 | 390,975,920.28 | 425,805,909.71 |
| 其中：应付票据 | 110,535,492.82 | 104,007,097.3 | 105,303,137.63 | 158,804,056.3 |
| 应付账款 | 312,790,548.84 | 393,246,062.23 | 285,672,782.65 | 267,001,853.41 |
| 合同负债 | 55,794,947.72 | 59,586,370.75 | 111,810,614.19 | 62,085,892.12 |
| 应付职工薪酬 | 73,356,340.12 | 66,094,252.55 | 80,560,952.73 | 83,025,885.06 |
| 应交税费 | 51,768,970.32 | 64,557,301.27 | 52,480,831.5 | 54,510,617.2 |
| 其他应付款合计 | 289,181,966.93 | 266,856,315.76 | 276,316,717.98 | 266,156,680.73 |
| 一年内到期的非流动负债 | 15,954,925.15 | 14,524,820.47 | 14,796,701.62 | 12,509,725.89 |
| 其他流动负债 | 6,144,161.86 | 8,006,980.03 | 8,715,425.73 | 6,379,224.86 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 936,632,024.16 | 987,889,894.8 | 941,663,492.8 | 916,478,213.35 |
| 非流动负债: | | | | |
| 租赁负债 | 7,597,964.98 | 8,731,659.79 | 8,689,178 | 8,859,840.44 |
| 长期应付款 | 53,962,129.16 | 53,316,901.16 | 52,671,673.16 | 52,056,584.51 |
| 预计负债 | 5,596,795.14 | 7,080,650.72 | 7,080,650.72 | 6,833,685 |
| 递延收益 | 28,536,368.41 | 27,890,529.8 | 28,619,706.93 | 30,759,997.29 |
| 递延所得税负债 | 56,829,367.66 | 45,428,856.27 | 46,994,868.34 | 49,329,311.59 |
| 其他非流动负债 | - | - | - | 10,706,300 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 152,522,625.35 | 142,448,597.74 | 144,056,077.15 | 158,545,718.83 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,089,154,649.51 | 1,130,338,492.54 | 1,085,719,569.95 | 1,075,023,932.18 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 317,952,508 | 317,952,508 | 317,952,508 | 317,952,508 |
| 资本公积 | 1,989,000,700.16 | 1,987,038,000.41 | 1,987,033,409.26 | 1,999,702,724.53 |
| 减:库存股 | 125,409,937.49 | 125,243,041.7 | 99,742,186.08 | 99,742,186.08 |
| 其他综合收益 | -14,079,617.69 | 10,385,264.27 | 10,372,509.73 | 23,378,187.61 |
| 盈余公积 | 158,976,254 | 158,976,254 | 158,976,254 | 158,976,254 |
| 未分配利润 | 1,927,887,457.5 | 1,993,733,132.08 | 1,856,118,434.59 | 1,807,246,071.82 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,254,327,364.48 | 4,342,842,117.06 | 4,230,710,929.5 | 4,207,513,559.88 |
| 少数股东权益 | 243,239,660.8 | 213,655,019.55 | 209,252,069.22 | 209,829,479.96 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,497,567,025.28 | 4,556,497,136.61 | 4,439,962,998.72 | 4,417,343,039.84 |
| 负债和股东权益合计 | 5,586,721,674.79 | 5,686,835,629.15 | 5,525,682,568.67 | 5,492,366,972.02 |
| 公告日期 | 2024-08-23 | 2024-04-26 | 2024-03-28 | 2023-10-27 |
| 审计意见(境内) | | | 标准无保留意见 | |